Bevacizumab and febrile neutropenia 
Bevacizumab and febrile neutropenia Patient Reports February 10, 2012
Bevacizumab Side Effects Report #4775284-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2005. Male patient, weighting 181.0 lb, was diagnosed with transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia
, pseudomonas infection, sputum culture positive, white blood cell count decreased. Bevacizumab dosage: 15MG.KG EVERY 3 WEEKS IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5275443-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 71 years of age, weighting 177.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonitis. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5550710-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 29, 2007. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, TAKEPRON, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.
Bevacizumab Side Effects Report #5582173-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 25, 2007. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, TAKEPRON, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.
Bevacizumab Side Effects Report #5773105-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 02, 2008. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, LANSOPRAZOLE, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.
Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.Bevacizumab Side Effects Report #5082186-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 400 MG GE Q 2 WEEKS IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, VICODIN, IMODIUM, ATIVAN, LISONOPRIL, NORVASC. Patient recovered.
Bevacizumab Side Effects Report #5697483-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Female patient, weighting 251.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation. Bevacizumab dosage: 900 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5865961-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 22, 2008. Female patient, weighting 242.5 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation. Bevacizumab dosage: 900 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5747603-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 523 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6047182-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 09, 2009. Female patient was diagnosed with ovarian cancer, ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5447680-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Male patient, 75 years of age, weighting 113.8 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: 10MG/KG DAY 1 Q 3 WEEKS IV (C1+C2). During the same period patient was treated with DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6042375-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2009. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, vomiting. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6062898-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2009. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia, vomiting. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, DOXYCYCLINE, ROXICET. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4612765-4
Bevacizumab side effect was reported by a Health Professional from on Mar 01, 2005. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypovolaemia, lobar pneumonia, lung infiltration, orthostatic hypotension. Bevacizumab dosage: 10 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4656692-5
Bevacizumab side effect was reported by a Physician from on Apr 22, 2005. Male patient, 52 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, febrile neutropenia, melaena, pancytopenia, rectal haemorrhage. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, MORPHINE SULPHATE, OXYCODONE, COLOXYL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4662972-X
Bevacizumab side effect was reported by a Physician from on Apr 28, 2005. Male patient, 52 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, febrile neutropenia, melaena, pancytopenia, rectal haemorrhage. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, MORPHINE SULPHATE, OXYCODONE, COLOXYL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4748464-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2005. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5332086-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 09, 2007. Female patient, weighting 107.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ALGINATE, TEPRENONE, MAGNESIUM SULPHATE, ETIZOLAM, ZOLMITRIPTAN, GUALENATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5626023-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 04, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 855 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, ZOLOFT, PLATELETS, CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5705141-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pulmonary embolism
. Bevacizumab dosage: 770 MG, Q2W. During the same period patient was treated with GEMZAR, CARBOPLATIN, OXYCONTIN, OXYCODONE, ATIVAN, LIPITOR, METOPROLOL TARTRATE, ISOSORBIDE DINITRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5775925-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis
. Bevacizumab dosage: 430 MG, TID. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 05/17/2008.Bevacizumab Side Effects Report #5887025-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 03, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 1100 MG, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5888604-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis
. Bevacizumab dosage: 430 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 05/17/2008.Bevacizumab Side Effects Report #6008985-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 02, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, pulmonary embolism
, tachycardia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN, PANTOPRAZOLE, LASIX. Patient died.Bevacizumab Side Effects Report #6023432-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 15, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, pulmonary embolism
, tachycardia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN, PANTOPRAZOLE, LASIX. Patient died.Bevacizumab Side Effects Report #6069570-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 23, 2009. Female patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, influenza like illness, pleural effusion. Bevacizumab dosage: 2750 MG, Q3W. During the same period patient was treated with FLUOROURACIL, STREPTOZOCIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5492369-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 10, 2007. Male patient, weighting 165.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea
, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5505748-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 24, 2007. Male patient, weighting 165.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5526450-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, weighting 158.7 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5583934-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, ileus. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5441432-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 28, 2007. Female patient, 22 years of age, weighting 88.00 lb, was diagnosed with ill-defined disorder and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 7.5 MG EVERY 21 DAYS IV. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, LIQUID TYLENOL, ENSURE, COLACE, SALINE RINSE, MAGIC MOUTHWASH. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5985969-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, wheezing. Bevacizumab dosage: 890MG Q 2 WEEKS IV. During the same period patient was treated with TEMOZOLOMIDE, CARDIZEM CD, COZAAR, ALLEGRA, FLONASE, FLOVENT, KEPPRA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5752668-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Male patient, 57 years of age, weighting 166.7 lb, was diagnosed with gastrointestinal disorder and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4975160-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 18, 2006. Male patient, 69 years of age, weighting 201.0 lb, was diagnosed with gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: BEVACIZUMAB 1380MG IV DRIP (EVERY 21 DAYS). During the same period patient was treated with OXALIPATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4997117-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Male patient, 69 years of age, weighting 201.0 lb, was diagnosed with gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Bevacizumab dosage: 15 MG/KG D1 EACH 21D IV DRIP. During the same period patient was treated with OXALIPLATIN SANOFI, DOCETAXEL AVENTIS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6002184-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, headache
, neutrophil count decreased. Bevacizumab dosage: 15 ML/KG,. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5394714-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 09, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hyperglycaemia, myocardial ischaemia, neutrophilia, pyrexia, renal haemorrhage. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, ASPIRIN, PANTOPRAZOLE, ENOXAPARIN, DIAMICRON, AUGMENTIN, NYSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5457171-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 03, 2007. Male patient, weighting 167.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pyrexia. Bevacizumab dosage: 355 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ACCUPRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5932983-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 13, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, multi-organ failure. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN HYDROCHLORIDE. Patient died.Bevacizumab Side Effects Report #5841134-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Aug 11, 2008. Male patient, 59 years of age, weighting 167.6 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticular perforation, febrile neutropenia, intestinal perforation, peritonitis. Bevacizumab dosage: 380 MG ONCE IV. Patient died on 07/11/2008.
Bevacizumab Side Effects Report #5479947-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 24, 2007. Male patient, weighting 202.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, febrile neutropenia, gastritis, lower respiratory tract infection, oesophagitis. Bevacizumab dosage: 460 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, NEORECORMON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5519432-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 01, 2007. Male patient, weighting 202.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: colitis, febrile neutropenia, gastritis, lower respiratory tract infection, oesophagitis. Bevacizumab dosage: 460 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, NEORECORMON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5557768-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2007. Female patient, weighting 303.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, febrile neutropenia, oesophageal candidiasis, vomiting. Bevacizumab dosage: 660 MG, Q3W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, NEUPOGEN, MODULON, IRON SUPPLEMENT, PANTOPRAZOLE, DOMPERIDONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5727451-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5844421-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 29, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal infection, anaemia, febrile neutropenia, metrorrhagia, nausea
, platelet count decreased, pyrexia, rash . Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, KYTRIL, DEXAMETHASONE PHOSPHATE, DECADRON SRC. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5119288-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2006. Female patient, 43 years of age, weighting 157.4 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacteria stool identified, febrile neutropenia, feeling abnormal. Bevacizumab dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5142675-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 11, 2006. Female patient, 43 years of age, weighting 157.4 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, febrile neutropenia, pleural effusion, white blood cell count decreased. Bevacizumab dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, PACLITAXEL, CYMBALTA, VICODIN, ALBUTEROL, ADVIL, DIPHENHYDRAMINE, PEPCID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5359131-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 01, 2007. Female patient, weighting 149.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pyrexia. Bevacizumab dosage: 1025 MG, Q3W. During the same period patient was treated with DOCETAXEL, ZOFRAN, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5694001-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 19, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 1025 MG, Q3W. During the same period patient was treated with DOCETAXEL, ZOFRAN, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5694013-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 19, 2008. Female patient, weighting 149.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pyrexia. Bevacizumab dosage: 1025 MG, Q3W. During the same period patient was treated with DOCETAXEL, ZOFRAN, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5831462-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 15, 2008. Female patient, weighting 217.6 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridial infection, febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, IMMOVANE, ADVIL, DIOVAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5978092-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 18, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia
, pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with TAXOTERE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5626825-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2008. Female patient, 61 years of age, weighting 123.0 lb, was diagnosed with breast cancer
, prophylaxis, insomnia, hypertension, medical diet, arthralgia, peptic ulcer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, liver function test abnormal. Bevacizumab dosage: 558 MG, UNK. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, NEULASTA, AMBIEN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, NAPROXEN, PREVACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5473743-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Female patient, 59 years of age, weighting 199.3 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholelithiasis, colitis, febrile neutropenia, septic shock. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, LEXAPRO, CITRACAL, ASCORBIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5406983-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2007. Male patient, weighting 116.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia, renal impairment, vomiting. Bevacizumab dosage: 10 MG/KG Q3WEEKS IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5744353-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5744354-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, body temperature decreased, febrile neutropenia, leukopenia, sepsis , septic shock. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5762591-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 27, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5762592-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 27, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5941912-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 21, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, EPIRUBICIN, FERROGRADUMET. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6014741-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, METOPROLOL TARTRATE, LEVOTHYROXINE, PANTOZOL, ANAFRANIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6018355-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, METOPROLOL, LEVOTHYROXINE, PANTOZOL, ANAFRANIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6065539-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 900 MG, UNK. During the same period patient was treated with DOCETAXEL, GRANISETRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6100814-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, mucosal inflammation. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ABRAXANE, ADRIAMYCIN PFS, CYTOXAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6112096-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, mucosal inflammation. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ABRAXANE, ADRIAMYCIN PFS, CYTOXAN, ROZEREM, REGLAN, OLANZAPINE, LEVOXYL, NEULASTA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6132272-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 10, 2009. Female patient was diagnosed with breast cancer
, febrile neutropenia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 1305 MG, Q3W. During the same period patient was treated with DOCETAXEL, ACUPAN, NEUPOGEN, DEXERYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5929315-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2008. Male patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, arthritis , confusional state, febrile neutropenia, fungal infection , monoparesis, pleuritic pain. Bevacizumab dosage: unknown. During the same period patient was treated with DAUNORUBICIN, CYTARABINE, VANCOMYCIN. Patient recovered.Bevacizumab Side Effects Report #5724823-1
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 30, 2008. Male patient, 63 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia, thrombocytopenia. Bevacizumab dosage: 350 MG OTHER IV. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4642124-X
Bevacizumab side effect was reported by a Health Professional from on Apr 21, 2005. Female patient, 63 years of age, weighting 240.5 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 5MG/KG IV BOLUS. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CA, FLUOROURACIL, ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5858851-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2008. Male patient, 55 years of age, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, lymphopenia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, RADIATION. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5848537-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2008. Female patient, weighting 118.8 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: culture urine positive, escherichia infection, febrile neutropenia, haematocrit decreased, thrombocytopenia, white blood cell count decreased. Bevacizumab dosage: 559 MG. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.